Study on an Investigational Quadrivalent Meningococcal Conjugate Vaccine (MenACYW Conjugate Vaccine) Administered as a Booster Dose in Children Vaccinated 5 Years Earlier as Toddlers
Condition: Meningococcal Infection Intervention: Biological: Meningococcal Polysaccharide (Serogroups A, C, W, and Y) Tetanus Toxoid Conjugate Vaccine Sponsor: Sanofi Pasteur, a Sanofi Company Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials
More News: ActHIB | Children | Men | Meningitis | Meningitis Vaccine | Research | Study | Tetanus | Tetanus Vaccine | Vaccines